Trial intelligence / Profile preview

Prognostic Value of ctDNA vs CTC in Colorectal Cancer

NCT02556281Completed

Sponsor
Rouen University Hospital
Start
Oct 2012
Primary completion
Jun 2019
Countries
1
01

Overview

Open-label, single-arm trial, sponsored by Rouen University Hospital. Primary endpoints: Presence of free tumoral DNA in blood at Day 1 and Disease Free Survival at 24 Months. Started Oct 2012; status: completed.

Beyond the preview

Go deeper on NCT02556281.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02556281.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call